摘要:
The present disclosure provides 15-oxo-EPA and 15-oxo-DGLA, compositions comprising 15-oxo-EPA and/or 15-oxo-DGLA, and methods of treating and/or preventing fibrosis, skin disorders, inflammation, kidney disease or renal dysfunction in a subject in need thereof by administering 15-oxo-EPA and/or 15-oxo-DGLA.
摘要:
The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.
摘要:
The present invention provides a composition, kit, and method for detecting hypoxia or diagnosing hypoxia-related diseases, the composition containing a material for detecting arachidonic acid and a derivative thereof. The composition, kit, and method according to the present invention can conveniently and promptly detect hypoxia through the detection of a biomarker in a biological sample, and thus can be useful in the prevention or early diagnose of diseases caused by hypoxia, the determination of the severity of diseases and therapeutic effects, tracking of diseases, or the like.
摘要:
A chemically-modified graphene includes a graphene layer and a plurality of functional groups that are grafted to the graphene layer and each of which is represented by —CO—R—COOH, wherein R is an optionally substituted C1-C5 alkylene group or an optionally substituted C1-C5 alkenylene group. A method for producing a chemically-modified grapheme includes subjecting a cyclic anhydride and graphite to a Friedel-Crafts reaction in the presence of a Lewis acid.
摘要:
The GPR40 receptor function regulator of the present invention, which comprises a compound having an aromatic ring and a group capable of releasing cation is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
摘要:
Diketoacids of Formula A are useful as inhibitors of viral polymerases. In particular hepatitis C virus RNA dependent RNA polymerase (HCV RdRp), hepatitis B virus polymerase (HBV pol) and reverse transcriptase of human immunodeficiency virus (HIV RT): The group R may be broadly chosen and is an organic moiety which contains 2 to 24 carbon atoms and includes an optionally cyclic or heterocyclic group in which the atom directly bonded to the adjacent carbonyl in the diketoacid is part of the ring structure.
摘要:
The present invention provides compounds that are inducers or inhibitors of apoptosis or apoptosis preceded by cell-cycle arrest. In addition, the present invention provides pharmaceutical compositions and methods for treating mammals with leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells.
摘要:
The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof, useful in the treatment of cancer and cancer which has developed a multidrug-resistant phenotype. Also provided are intermediates useful for preparing said epothilones.
摘要:
This invention pertains to a process for preparing diacetylenics, to diacetylenic compounds and to reduced diacetylenic compounds. The process includes the steps of reacting coupling an acetylenic acid in presence of cupric chloride in Ethylamine and hydroxylamine hydrochloride to form a diacetylenic diacid; reacting the diacetylenic diacid with a lithium compound, trimethylsilyl chloride and hydrochloric acid to form a diacetylenic compound; and reducing the diacetylenic compound to a reduced diacetylenic compound. The diacetylenic compounds have the formula COOH—(CH2)m—C≡C—C≡C—(CH2)m—C(═O)—R or R—C(═O)—(CH2)m—C≡C—C≡C—(CH2)m—C(═O)—R and the reduced cyclic diacetylenic compounds have the formula COOH—(CH2)m—C≡C—C≡C—(CH2)m—CH2—R or R—CH2—(CH2)m—C≡C—C≡C—(CH2)m—CH2—R, where m is 1-18 and R is selected from alkyl groups of 1-10 and cyclic groups containing 6-35 carbon atoms and aryl moieties
摘要翻译:本发明涉及制备二乙炔基化合物,二乙炔化合物和还原二炔化合物的方法。 该方法包括使乙酸氯化物在乙胺和盐酸羟胺存在下偶联乙酸以形成二乙炔二酸的步骤; 使二乙炔二酸与锂化合物,三甲基甲硅烷基氯和盐酸反应,形成二乙炔化合物; 并将二乙炔化合物还原成还原的二乙炔化合物。 二乙炔化合物具有式COOH-(CH2)mC = CC = C-(CH2)mC(= O)-R或RC(= O) - (CH2)mC = CC = C-(CH2)mC(= O )-R并且还原的环状二炔化合物具有式COOH-(CH 2)m C = CC = C-(CH 2)m -CH 2 -R或R-CH 2 - (CH 2)m C = CC = C-(CH 2)m - CH2-R,其中m为1-18,R选自1-10的烷基和含有6-35个碳原子的环状基团和芳基部分
摘要:
The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof, useful in the treatment of cancer and cancer which has developed a multidrug-resistant phenotype. Also provided are intermediates useful for preparing said epothilones.